Company Shown To Have Concealed Falsified Study Results In Stock Drop Suit
NEW YORK — An Israeli clinical stage biopharmaceutical company that develops combination drugs for the treatment of osteoarthritis and hypertension issued material misrepresentations and omissions concealing that the company’s CEO falsified...To view the full article, register now.
Already a subscriber? Click here to view full article